BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24372487)

  • 1. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
    Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
    Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
    J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to differentiate benign from malignant myometrial tumours using MR imaging.
    Thomassin-Naggara I; Dechoux S; Bonneau C; Morel A; Rouzier R; Carette MF; Daraï E; Bazot M
    Eur Radiol; 2013 Aug; 23(8):2306-14. PubMed ID: 23563602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
    Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI appearance of mesenchymal tumors of the uterus.
    Cornfeld D; Israel G; Martel M; Weinreb J; Schwartz P; McCarthy S
    Eur J Radiol; 2010 Apr; 74(1):241-9. PubMed ID: 19349135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.
    Tamura R; Kashima K; Asatani M; Nishino K; Nishikawa N; Sekine M; Serikawa T; Enomoto T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1042-7. PubMed ID: 24927248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
    Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
    Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
    Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
    Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
    Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
    Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of uterine cotyledonoid dissecting leiomyoma with adenomyosis.
    Shimizu A; Tanaka H; Iwasaki S; Wakui Y; Ikeda H; Suzuki A
    Diagn Pathol; 2016 Aug; 11(1):69. PubMed ID: 27491369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
    Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
    AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.